Welcome to our dedicated page for Venus Concept SEC filings (Ticker: VERO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Venus Concept Inc. (NASDAQ: VERO) SEC filings page on Stock Titan provides direct access to the company’s regulatory disclosures, along with AI-powered tools to help interpret them. Venus Concept is a medical aesthetic technology company that files a range of documents with the U.S. Securities and Exchange Commission, including Current Reports on Form 8-K, annual reports on Form 10-K and quarterly reports on Form 10-Q.
For Venus Concept, Form 8-K filings are particularly important because they document material events such as bridge loan amendments, consent agreements, delayed drawdowns, debt-to-equity exchanges and amendments to preferred stock designations. Recent 8-Ks describe multiple amendments to the company’s Main Street Priority Loan and Bridge Loan with affiliates of Madryn Health Partners, waivers of minimum liquidity covenants, and extensions of loan maturity dates. Other 8-Ks report the exchange of subordinated convertible notes for shares of Series Y Convertible Preferred Stock and changes to the certificate of designations for that preferred stock.
Investors can also use this page to locate earnings-related filings, such as 8-Ks furnished under Item 2.02 that attach press releases for quarterly results, where Venus Concept discusses revenue by region (United States and International), revenue by product category (Venus Prime / subscription systems, products – systems, products – other, and services), gross profit and operating loss. These filings complement the more detailed financial statements and risk disclosures found in the company’s 10-Q and 10-K reports.
Stock Titan enhances these documents with AI-powered summaries and highlights, helping readers quickly identify key points in long filings, such as new financing terms, covenant waivers, strategic transaction agreements (including the definitive agreement to sell the Venus Hair business), and changes to capital structure. Users can also review insider and related-party information where reported, and track how Venus Concept’s financing arrangements and strategic initiatives evolve over time through successive filings.
Venus Concept Inc. is filing post-effective amendments to multiple Form S-3 registration statements to deregister all unsold securities that had previously been registered. This step follows a Board decision on January 20, 2026 to voluntarily delist the company’s common stock from the Nasdaq Capital Market and terminate its registration under U.S. federal securities laws.
The company also plans to suspend its duty to file periodic reports and other information with the SEC, meaning investors may receive less frequent and less standardized public financial disclosure going forward.
Venus Concept Inc. is filing post-effective amendments to multiple Form S-3 registration statements to deregister all unsold securities that had been previously registered. This step follows the Board’s January 20, 2026 approval of a plan to voluntarily delist the company’s common stock from the Nasdaq Capital Market, suspend its duty to file periodic reports with the SEC, and terminate the registration of its common stock under U.S. federal securities laws. Together, these actions move the company away from U.S. public market reporting and capital-raising structures tied to those S-3 shelf registrations.
Venus Concept Inc. has filed post-effective amendments to multiple existing shelf registration statements on Form S-3 to deregister all securities that remain unsold under those registrations. This is an administrative step that removes unused capacity to issue securities that had previously been cleared for potential sale.
The company notes that its board of directors had previously approved a plan on January 20, 2026 to voluntarily delist its common stock from the Nasdaq Capital Market, suspend its duty to file periodic reports and other information with the SEC, and terminate the registration of its common stock under U.S. federal securities laws. These actions collectively move Venus Concept away from being a U.S. exchange-listed and SEC-reporting company.
Venus Concept Inc. filed post-effective amendments to multiple Form S-3 registration statements to deregister all unsold securities that had previously been registered for potential sale. This step follows the board’s January 20, 2026 decision to voluntarily delist the company’s common stock from the Nasdaq Capital Market.
The board also approved suspending the company’s obligation to file periodic reports and other information with the SEC and terminating the registration of its common stock under U.S. federal securities laws. These changes collectively move Venus Concept toward operating as a non‑reporting, non‑exchange‑listed company in the United States.
Venus Concept Inc. filed post-effective amendments to multiple Form S-3 registration statements to deregister all unsold securities that had been previously registered. This is an administrative step that removes unused shelf capacity for issuing securities to the public.
The company notes that its board of directors approved a plan on January 20, 2026 to voluntarily delist its common stock from the Nasdaq Capital Market, suspend its duty to file periodic reports with the SEC, and terminate registration of its common stock under U.S. federal securities laws. The amendments are signed on behalf of the company by its chief executive officer.
Venus Concept Inc. is filing post-effective amendments to multiple Form S-3 registration statements to deregister all unsold securities that had been available for future offerings. This administrative step follows the Board’s January 20, 2026 approval of a plan to voluntarily delist its common stock from the Nasdaq Capital Market, suspend its SEC reporting obligations, and terminate registration of its common stock under U.S. federal securities laws.
Venus Concept Inc. is filing a post-effective amendment to its Form S-1 registration statements to deregister all shares of common stock that were previously registered but remain unsold. This action also terminates the effectiveness of those registration statements as of the filing date.
The company’s board had earlier approved a plan to voluntarily delist its common stock from the Nasdaq Capital Market, suspend its duty to file periodic reports with the SEC, and terminate its U.S. federal registration. Ending these S-1 offerings and deregistering unsold shares aligns with that broader plan.
Venus Concept Inc. is filing a post-effective amendment to its Form S-1 registration statements to deregister all unsold shares of its common stock that had been registered for potential sale. This follows the board’s January 20, 2026 decision to voluntarily delist the common stock from the Nasdaq Capital Market and terminate its U.S. securities law registration obligations. With this step, the company formally ends all offerings under these S-1 registration statements and terminates their effectiveness.
Venus Concept Inc. entered into several financing agreements with Madryn Health Partners on January 29, 2026 to address near-term liquidity. A Consent Agreement under the Main Street Priority Loan waives certain minimum liquidity requirements through February 13, 2026 and allows the February 8, 2026 cash interest due under each Note to be applied to principal instead.
The company also signed a Twenty Fifth Bridge Loan Amendment, extending the Bridge Loan maturity date from January 31, 2026 to February 13, 2026, waiving certain minimum liquidity requirements through that date, and increasing the delayed draw commitment from $26,000,000 to $28,000,000. On the same day, Venus Concept completed a Seventeenth Delayed Drawdown of $2,000,000 under the Bridge Financing, which bears interest at 12% per year. The company plans to use net proceeds for general working capital needs.
The issuer has filed a Form 25 to remove the listing and registration of its common stock under Section 12(b) of the Securities Exchange Act of 1934. This step means its $0.001 par value common shares will no longer be listed and/or registered on the referenced securities exchange once the process is completed.